Clinical Trial Update: Comparison of Combination Disease Modifying Antirheumatic Drugs With Methotrexate Therapy in Early Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing combination disease-modifying antirheumatic drugs with methotrexate therapy in early rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Jawaharlal Institute of Postgraduate Medical Education & Research | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED